Aurinia Pharmaceuticals Inc
NASDAQ:AUPH

Watchlist Manager
Aurinia Pharmaceuticals Inc Logo
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Watchlist
Price: 8.14 USD -1.45%
Market Cap: 1.2B USD
Have any thoughts about
Aurinia Pharmaceuticals Inc?
Write Note

Aurinia Pharmaceuticals Inc
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Aurinia Pharmaceuticals Inc
Total Current Liabilities Peer Comparison

Comparables:
B
DRUG
TH
RPTX
COV
EDT

Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Total Current Liabilities
$78.6m
CAGR 3-Years
28%
CAGR 5-Years
42%
CAGR 10-Years
40%
B
Bright Minds Biosciences Inc
CNSX:DRUG
Total Current Liabilities
CA$638.6k
CAGR 3-Years
62%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Total Current Liabilities
$52.9m
CAGR 3-Years
6%
CAGR 5-Years
14%
CAGR 10-Years
21%
Repare Therapeutics Inc
NASDAQ:RPTX
Total Current Liabilities
$39.1m
CAGR 3-Years
53%
CAGR 5-Years
83%
CAGR 10-Years
N/A
Covalon Technologies Ltd
XTSX:COV
Total Current Liabilities
CA$4.4m
CAGR 3-Years
-41%
CAGR 5-Years
-24%
CAGR 10-Years
9%
Spectral Medical Inc
TSX:EDT
Total Current Liabilities
CA$33.9m
CAGR 3-Years
150%
CAGR 5-Years
107%
CAGR 10-Years
29%

See Also

What is Aurinia Pharmaceuticals Inc's Total Current Liabilities?
Total Current Liabilities
78.6m USD

Based on the financial report for Sep 30, 2024, Aurinia Pharmaceuticals Inc's Total Current Liabilities amounts to 78.6m USD.

What is Aurinia Pharmaceuticals Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
40%

Over the last year, the Total Current Liabilities growth was 6%. The average annual Total Current Liabilities growth rates for Aurinia Pharmaceuticals Inc have been 28% over the past three years , 42% over the past five years , and 40% over the past ten years .

Back to Top